UNIVERSITY OF UTAH
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1850-02-28
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.utah.edu
Home-based HIIT to Improve CRC Survivorship: Feasibility and Relationship With Novel Surrogate Biomarkers of CRC Recurrence
Not Applicable
Completed
- Conditions
- Colorectal CancerRectal NeoplasmsColorectal CarcinomaRectal CancerColorectal NeoplasmsColonic NeoplasmsColonic Cancer
- Interventions
- Behavioral: Home-based moderate-intensity continuous exerciseBehavioral: Home-based high-intensity interval training
- First Posted Date
- 2019-09-06
- Last Posted Date
- 2023-03-22
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 7
- Registration Number
- NCT04080414
- Locations
- 🇺🇸
Intermountain Medical Center, Murray, Utah, United States
🇺🇸Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah, United States
Radiation Dose in Humans From Orally Administered Tc99m-Heparin
Early Phase 1
Completed
- Conditions
- Eosinophilic Esophagitis
- Interventions
- Radiation: Computerized Tomography scanRadiation: Single Photon Emission Computed Tomography scansRadiation: Planar ImagesProcedure: Esophagogastroduodenoscopy
- First Posted Date
- 2019-08-28
- Last Posted Date
- 2021-05-03
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 8
- Registration Number
- NCT04069429
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for Melanoma
Phase 2
Completed
- Conditions
- Melanoma (Skin)
- Interventions
- First Posted Date
- 2019-08-26
- Last Posted Date
- 2022-02-18
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 95
- Registration Number
- NCT04066725
- Locations
- 🇺🇸
Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
Acupuncture Treatment of Chemotherapy-Induced Peripheral Neuropathy in Women
Not Applicable
Terminated
- Conditions
- Chemotherapy-induced Peripheral NeuropathyBreast Cancer FemaleGynecologic Cancer
- Interventions
- Device: Acupuncture
- First Posted Date
- 2019-08-26
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 3
- Registration Number
- NCT04067544
- Locations
- 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Accuracy of Rib Palpation for Dry Needling of Deep Periscapular Musculature, Measured With Ultrasound
Completed
- Conditions
- Trigger Point Pain, Myofascial
- Interventions
- Diagnostic Test: Palpation
- First Posted Date
- 2019-08-26
- Last Posted Date
- 2023-05-11
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 100
- Registration Number
- NCT04066166
Metabolomic and Inflammatory Effects of Oral Aspirin (ASA) in Subjects at Risk for Melanoma
- First Posted Date
- 2019-08-20
- Last Posted Date
- 2022-02-18
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 41
- Registration Number
- NCT04062032
- Locations
- 🇺🇸
Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
Mechanisms of CBD for Chronic Pain
- First Posted Date
- 2019-08-05
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 24
- Registration Number
- NCT04044729
- Locations
- 🇺🇸
University Of Utah, Salt Lake City, Utah, United States
Asprin Dosing Estimator in Healthy Adults
- First Posted Date
- 2019-07-31
- Last Posted Date
- 2022-03-11
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 57
- Registration Number
- NCT04040465
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
Peer to Peer Programs for Military Suicide Prevention
Not Applicable
Completed
- Conditions
- Suicide
- Interventions
- Behavioral: Peer to peer program intervention
- First Posted Date
- 2019-07-16
- Last Posted Date
- 2022-10-06
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 2055
- Registration Number
- NCT04021758
- Locations
- 🇺🇸
Whiteman Air Force Base, Base De La Fuerza Aérea Whiteman, Missouri, United States
Perioperative Atezolizumab With MVA-BN-Brachyury and PROSTVAC For Intermediate-Risk And High-Risk Localized Prostate Cancer
Phase 2
Withdrawn
- Conditions
- Prostate Adenocarcinoma
- Interventions
- Combination Product: MVA-BN-Brachyury
- First Posted Date
- 2019-07-15
- Last Posted Date
- 2021-09-22
- Lead Sponsor
- University of Utah
- Registration Number
- NCT04020094
- Locations
- 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
© Copyright 2025. All Rights Reserved by MedPath